Penumbra, Inc. to Present at the Canaccord Genuity 42nd Annual Growth Conference
Penumbra, Inc. (NYSE: PEN) will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 8:30am ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 8:30am ET. The event will be held in Alameda, California.
A webcast of the presentation will be accessible on the company's investor website for at least two weeks after the event. Penumbra is dedicated to innovative healthcare solutions, operating in over 100 countries.
Details
News Market Reaction – PEN
The recorded move for PEN in the trading session of this news was +3.35%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALAMEDA, Calif., July 27, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022.
Event: | Canaccord Genuity 42nd Annual Growth Conference |
Date: | Wednesday, August 10, 2022 |
Time: | 8:30am ET / 5:30am PT |
A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference-301591303.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.